UAE First Country To Approve New Treatment
- Publish date: Thursday، 22 December 2022
- Related articles
- WHO Praises Kuwait’s Healthcare System
- MP Calls to Expedite Health Assurance Hospitals for Expats
- Kuwait's New Residency Law Proposes 3-Month Visit Visa and Much More
According to the Ministry of Health and Prevention (MoHAP), Sotrovimab, COVID-19 vaccine has been approved for emergency use only making the UAE the first country in the world to licence its use.
The UAE first country in the world to use the medicine 'Sotrovimab-vir-7831' against Covid-19#COVID_19#TogetherWeRecover#TogetherForYourWellness#ChoosetoVaccinate#PfizerBiontech@mohapuae pic.twitter.com/xwR1EmPjy3
— UAE Forsan (@UAE_Forsan) May 29, 2021
This comes after the US Food and Drug Administration (FDA) gave an emergency use authorization to the antibody treatment.
.
— وزارة الصحة ووقاية المجتمع - MOHAP UAE (@mohapuae) May 29, 2021
آخر الإحصائيات حول إصابات فيروس كوفيد 19 في الإمارات
.
.
The latest update of Coronavirus (Covid 19) in the UAE
. #نلتزم_لننتصر #التزامك_حياتك#ملتزمون_يا_وطن#كوفيد19#وزارة_الصحة_ووقاية_المجتمع_الإمارات#we_commit_until_we_succeed #covid19#mohap_uae pic.twitter.com/gnDF1nI0yJ
Sotrovimab, provided by healthcare company GSK, can reduce hospitalization of patients for more than 24 hours and fatalities by as much as 85 per cent when administered as an early treatment for COVID-19.
It can now be used with patients aged 12 years and above with mild to moderate symptoms of the coronavirus who are at risk of hospitalization or death.
In pre-clinical studies, Sotrovimab has demonstrated effectiveness as a monotherapy against widely circulating variants of the disease.
Image Credit: Unsplash
This article was previously published on UAE Moments.To see the original article, click here